| Stock | PriceCurrent trading price. | Market CapTotal market capitalization. | FKPrice to Earnings ratio. | PD/DDPrice to Book ratio. | EV/EBITDAEnterprise Value / EBITDA. | ROICReturn on Invested Capital. | WACCWeighted Average Cost of Capital (WACC). | PUSLAFinancial health score (0-100). | DamodaranValuation score. | Intrinsic ValueFair value via DCF model. | Potential %Expected upside potential %. | Dalio RiskDalio Debt Cycle Score | Debt/EquityDebt to Equity ratio. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OMV
|
68.50 | 22.3B | 9.02 | 1.25 | 4.79 | 8.1% | 6.0% | 72 | 67 | 98.86 | +33.2% | 73 | 0.45 |
|
EVN
|
29.45 | 5.3B | 10.53 | 0.79 | 5.67 | 4.5% | 7.7% | 59 | 37 | 33.43 | +9.7% | 64 | 0.18 |
|
VER
|
59.30 | 20.6B | 16.21 | 1.96 | 7.72 | 14.8% | 8.1% | 50 | 48 | 47.41 | -15.0% | 84 | 0.02 |
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.